4.6 Article

4-[(5-Methyl-1H-pyrazol-3-yl)amino]-2H-phenyl-1-phthalazinone Inhibits MCPyV T Antigen Expression in Merkel Cell Carcinoma Independent of Aurora Kinase A

Journal

CANCERS
Volume 15, Issue 9, Pages -

Publisher

MDPI
DOI: 10.3390/cancers15092542

Keywords

Merkel cell carcinoma; polyomavirus; large T antigen; phthalazinone pyrazole; glycogen synthase kinase 3; GSK3

Categories

Ask authors/readers for more resources

The treatment of Merkel cell carcinoma, a deadly skin cancer caused by Merkel cell polyomavirus, is challenging. This study identified a compound, previously described as an inhibitor of Aurora kinase A, that represses the growth of Merkel cell carcinoma cells by inhibiting the expression of viral proteins. However, it was found that the effect is not related to the inhibition of Aurora kinase A, but possibly due to an unknown GSK3-inhibitory activity of the compound, which was demonstrated to have therapeutic potential in immunocompromised mice.
Treatment of Merkel cell carcinoma-a deadly skin cancer frequently caused by the Merkel cell polyomavirus-still poses challenges. Since the tumor cells depend on expression of viral oncogenes-named T antigens-targeting the expression of these T antigens appears as a potential therapeutic strategy. Therefore, we screened a kinase inhibitor library for compounds repressing growth of Merkel cell carcinoma cells specifically by inhibiting expression of these viral proteins and identified a compound previously described as an inhibitor of Aurora kinase A (AURKA). However, we provide evidence that the T-antigen repressing effect is not related to inhibition of AURKA but probably to a hitherto unknown GSK3-inhibitory activity of the compound, whose potential use a therapeutic is demonstrated in immunocompromised mice transplanted with human MCC. Merkel cell carcinoma (MCC) is frequently caused by the Merkel cell polyomavirus (MCPyV), and MCPyV-positive tumor cells depend on expression of the virus-encoded T antigens (TA). Here, we identify 4-[(5-methyl-1H-pyrazol-3-yl)amino]-2H-phenyl-1-phthalazinone (PHT)-a reported inhibitor of Aurora kinase A-as a compound inhibiting growth of MCC cells by repressing noncoding control region (NCCR)-controlled TA transcription. Surprisingly, we find that TA repression is not caused by inhibition of Aurora kinase A. However, we demonstrate that beta-catenin-a transcription factor repressed by active glycogen synthase kinase 3 (GSK3)-is activated by PHT, suggesting that PHT bears a hitherto unreported inhibitory activity against GSK3, a kinase known to function in promoting TA transcription. Indeed, applying an in vitro kinase assay, we demonstrate that PHT directly targets GSK3. Finally, we demonstrate that PHT exhibits in vivo antitumor activity in an MCC xenograft mouse model, suggesting a potential use in future therapeutic settings for MCC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available